TScan Therapeutics • TCRX
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. David P. Southwell$385.4M
Market Cap • 25/04/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
Waltham
Sede • Massachusetts138
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TCRXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.